Literature DB >> 4394368

Autonomic control of insulin secretion and the treatment of heart failure.

P A Majid, C Saxton, J R Dykes, M C Galvin, S H Taylor.   

Abstract

To investigate the role of the autonomic nervous system in controlling insulin secretion 13 normal subjects and 5 patients with heart failure underwent insulin secretion tests. Alpha-adrenergic stimulation and beta-receptor blockade significantly depressed the secretion of insulin in response to intravenous tolbutamide in normal subjects, while both alpha-blockade and beta-stimulation significantly increased the insulin secretion response in both normal subjects and patients in heart failure. Parasympathetic stimulation and blockade had no significant effect on the insulin secretion response. These findings suggest that drugs that block the alpha-adrenergic receptors or stimulate the beta-adrenergic receptors by their ability to counteract the insulin suppression resulting from increased sympathetic nervous activity may play a vital metabolic part in the deranged metabolism of the failing heart in addition to their direct haemodynamic benefits.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4394368      PMCID: PMC1819655          DOI: 10.1136/bmj.4.5731.328

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  32 in total

1.  Inhibition of insulin secretion by a phaeochromocytoma.

Authors:  J F Wilber; J R Turtle; N A Crane
Journal:  Lancet       Date:  1966-10-01       Impact factor: 79.321

2.  Rapid rise of insulin concentration in the plasma after intravenous administration of sodium tobutamide.

Authors:  D Maingay; H A de Ruyter; J L Touber; R J Croughs; E Schopman; R M Lequin
Journal:  Lancet       Date:  1967-02-18       Impact factor: 79.321

3.  Inhibition of insulin secretion by infused epinephrine in rhesus monkeys.

Authors:  A O Kris; R E Miller; F E Wherry; J W Mason
Journal:  Endocrinology       Date:  1966-01       Impact factor: 4.736

Review 4.  Myocardial metabolism in cardiac hypoxia.

Authors:  J Scheuer
Journal:  Am J Cardiol       Date:  1967-03       Impact factor: 2.778

5.  Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro.

Authors:  H G Coore; P J Randle
Journal:  Biochem J       Date:  1964-10       Impact factor: 3.857

6.  Effects of stimulation of the vagus nerve on insulin secretion.

Authors:  A Kaneto; K Kosaka; K Nakao
Journal:  Endocrinology       Date:  1967-03       Impact factor: 4.736

7.  Effect of selected hexoses, of epinephrine and of glucagon on insulin secretion in man.

Authors:  J H Karam; S G Grasso; L C Wegienka; G M Grodsky; P H Forsham
Journal:  Diabetes       Date:  1966-08       Impact factor: 9.461

8.  The effect of epinephrine on immunoreactive insulin levels in man.

Authors:  D Porte; A L Graber; T Kuzuya; R H Williams
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

9.  A receptor mechanism for the inhibition of insulin release by epinephrine in man.

Authors:  D Porte
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

10.  Inhibition of insulin release by norepinephrine in man.

Authors:  D Porte; R H Williams
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

View more
  9 in total

Review 1.  Insulin and heart failure.

Authors:  S H Taylor
Journal:  Br Heart J       Date:  1971-05

2.  The mechanism of insulin secretion after oral glucose administration. II. Reflex insulin secretion in conscious dogs bearing fistulas of the digestive tract by sham-feeding of glucose or tap water.

Authors:  H Hommel; U Fischer; K Retzlaff; H Knöfler
Journal:  Diabetologia       Date:  1972-04       Impact factor: 10.122

3.  Insulin secretion after open-heart surgery with particular respect to pathogenesis of low cardiac output state.

Authors:  P A Majid; P Ghosh; B C Pakrashi; M Ionescu; J R Dykes; S H Taylor
Journal:  Br Heart J       Date:  1971-01

4.  Plasma insulin in heart disease.

Authors:  S H Taylor; P A Majid; J R Dykes; B Sharma; C Saxton
Journal:  Proc R Soc Med       Date:  1971-05

5.  Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.

Authors:  M Velasco; H Silva; E Feldstein; R Pellicer; J Morillo; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Plasma insulin levels and beta-adrenoceptor antagonists. The effects of cardioselective and non-cardioselective beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on basal insulin level and insulin level after glucose stimulation in normoglycemic dogs.

Authors:  W Conca; A Beck; S Bacher; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

7.  Treatment of chronic heart failure with slow release phentolamine.

Authors:  A J Georgopoulos; A Valasidis; D Siourthas
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

8.  The effect of selected antiarrhythmic drugs on neutrophil free oxygen radicals production measured by chemiluminescence.

Authors:  T Siminiak; H Wysocki; A Veit; H R Maurer
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

9.  Plasma insulin levels and beta-adrenoceptor antagonists. Relevance of the steric configuration of beta-adrenoceptor antagonists to their effect on glucose tolerance.

Authors:  A Beck; W Conca; S Bacher; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.